Authors
Husam Kivan, Hamza Sondoqah, Abdulah Mohammad Abd Alhamed Abou Kaff, Mohamed Eldahrawy, Areej Makeineldein Mustafa, April Htoon, Farah Qandeel, Ahmad Alababneh, Ammar Khalid, Ahmed L Youseif, Hamzah M Alghzawi, Mohamed Ibraheem
Published in
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. Volume 31. Issue 6.
Abstract
Low-voltage areas (LVAs) may represent arrhythmogenic substrate in persistent atrial fibrillation (AF), but the benefit of adjunctive LVA-guided ablation remains uncertain.
We performed a PRISMA-compliant systematic review and random-effects meta-analysis of randomized controlled trials comparing LVA-guided ablation with non-LVA-guided strategies in persistent or non-paroxysmal AF. Searches were updated through September 2, 2026. The primary outcome was atrial arrhythmia recurrence; time-to-event hazard ratios (HRs), repeat ablation, procedural outcomes, and safety were secondary outcomes.
Eight randomized trials involving 1656 patients contributed to the primary analysis. LVA-guided ablation reduced atrial arrhythmia recurrence (RR 0.77, 95% CI 0.65-0.91; p = 0.003; I2 = 36.6%), although the 95% prediction interval included no benefit (0.51-1.17). The pooled HR was also favorable (HR 0.71, 95% CI 0.53-0.96; p = 0.026; I2 = 67.2%). Omitting IDEAL-AF attenuated both estimates and eliminated most heterogeneity. Mapping-before-randomization trials with documented LVAs did not differ from randomization-before-mapping trials (interaction p = 0.76). Repeat ablation was reduced (RR 0.69, 95% CI 0.49-0.97), while procedure time, fluoroscopy time, and major safety outcomes were not significantly different.
LVA-guided ablation was associated with fewer atrial arrhythmia recurrences and repeat procedures, but the pooled effect was strongly influenced by IDEAL-AF and remained heterogeneous across documented-LVA trials. Standardized mapping and ablation protocols are needed before the magnitude of benefit can be considered established.
PMID:
43046627
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0